203 related articles for article (PubMed ID: 28425496)
1. 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner.
Pitts EG; Minerva AR; Chandler EB; Kohn JN; Logun MT; Sulima A; Rice KC; Howell LL
Neuropsychopharmacology; 2017 Sep; 42(10):1962-1971. PubMed ID: 28425496
[TBL] [Abstract][Full Text] [Related]
2. Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat.
Morley KC; Arnold JC; McGregor IS
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):648-57. PubMed ID: 15908091
[TBL] [Abstract][Full Text] [Related]
3. Tolerance to 3,4-methylenedioxymethamphetamine is associated with impaired serotonin release.
Jones K; Brennan KA; Colussi-Mas J; Schenk S
Addict Biol; 2010 Jul; 15(3):289-98. PubMed ID: 20477756
[TBL] [Abstract][Full Text] [Related]
4. Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates.
Fantegrossi WE; Bauzo RM; Manvich DM; Morales JC; Votaw JR; Goodman MM; Howell LL
Psychopharmacology (Berl); 2009 Aug; 205(2):337-47. PubMed ID: 19421742
[TBL] [Abstract][Full Text] [Related]
5. A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").
Thompson MR; Callaghan PD; Hunt GE; Cornish JL; McGregor IS
Neuroscience; 2007 May; 146(2):509-14. PubMed ID: 17383105
[TBL] [Abstract][Full Text] [Related]
6. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
Fantegrossi WE; Ullrich T; Rice KC; Woods JH; Winger G
Psychopharmacology (Berl); 2002 Jun; 161(4):356-64. PubMed ID: 12073162
[TBL] [Abstract][Full Text] [Related]
7. Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.
Ball KT; Rebec GV
Psychopharmacology (Berl); 2005 Oct; 181(4):676-87. PubMed ID: 16001122
[TBL] [Abstract][Full Text] [Related]
8. Role of 5-HT
Esaki H; Sasaki Y; Nishitani N; Kamada H; Mukai S; Ohshima Y; Nakada S; Ni X; Deyama S; Kaneda K
Eur J Pharmacol; 2023 May; 946():175653. PubMed ID: 36907260
[TBL] [Abstract][Full Text] [Related]
9. Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity.
Bull EJ; Hutson PH; Fone KC
Neuropharmacology; 2004 Feb; 46(2):202-10. PubMed ID: 14680758
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice.
Fantegrossi WE; Godlewski T; Karabenick RL; Stephens JM; Ullrich T; Rice KC; Woods JH
Psychopharmacology (Berl); 2003 Mar; 166(3):202-11. PubMed ID: 12563544
[TBL] [Abstract][Full Text] [Related]
11. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans.
Liechti ME; Saur MR; Gamma A; Hell D; Vollenweider FX
Neuropsychopharmacology; 2000 Oct; 23(4):396-404. PubMed ID: 10989266
[TBL] [Abstract][Full Text] [Related]
12. Discriminative-Stimulus Effects of Synthetic Cathinones in Squirrel Monkeys.
Wakeford AGP; Sherwood AM; Prisinzano TE; Bergman J; Kohut SJ; Paronis CA
Int J Neuropsychopharmacol; 2021 Aug; 24(8):656-665. PubMed ID: 33909067
[TBL] [Abstract][Full Text] [Related]
13. MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635.
Hunt GE; McGregor IS; Cornish JL; Callaghan PD
Brain Res Bull; 2011 Aug; 86(1-2):65-73. PubMed ID: 21745546
[TBL] [Abstract][Full Text] [Related]
14. Ecstasy induces apoptosis via 5-HT(2A)-receptor stimulation in cortical neurons.
Capela JP; Fernandes E; Remião F; Bastos ML; Meisel A; Carvalho F
Neurotoxicology; 2007 Jul; 28(4):868-75. PubMed ID: 17572501
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging in human MDMA (Ecstasy) users.
Cowan RL; Roberts DM; Joers JM
Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
[TBL] [Abstract][Full Text] [Related]
16. Oral administration of (+/-)3,4-methylenedioxymethamphetamine and (+)methamphetamine alters temperature and activity in rhesus macaques.
Crean RD; Davis SA; Taffe MA
Pharmacol Biochem Behav; 2007 May; 87(1):11-9. PubMed ID: 17475314
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).
Curry DW; Berro LF; Belkoff AR; Sulima A; Rice KC; Howell LL
Neuropharmacology; 2019 Jun; 151():13-20. PubMed ID: 30922893
[TBL] [Abstract][Full Text] [Related]
18. The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.
Murnane KS; Kimmel HL; Rice KC; Howell LL
Horm Behav; 2012 Feb; 61(2):181-90. PubMed ID: 22197270
[TBL] [Abstract][Full Text] [Related]
19. Repeated adolescent MDMA ("Ecstasy") exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist.
Biezonski DK; Courtemanche AB; Hong SB; Piper BJ; Meyer JS
Brain Res; 2009 Feb; 1252():87-93. PubMed ID: 19059385
[TBL] [Abstract][Full Text] [Related]
20. 50-kHz calls in rats: effects of MDMA and the 5-HT(1A) receptor agonist 8-OH-DPAT.
Sadananda M; Natusch C; Karrenbauer B; Schwarting RK
Pharmacol Biochem Behav; 2012 Apr; 101(2):258-64. PubMed ID: 22285322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
